« Back to Record
Sprangers, B., Decoo, D., Dive, D., Lysandropoulos, A., Vanopdenbosch, L., & Bovy, C. (2018). Management of adverse renal events related to alemtuzumab treatment in multiple sclerosis: a Belgian consensus. Acta neurologica belgica, 118(2), 143-151. doi:10.1007/s13760-017-0864-x
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/272538



